S'abonner à DNDi_HQ sur Twitter
DNDi News

DNDi News

 

Click here
To subscribe to DNDi monthly e-News !

 

DNDi News
 
December 13, 2012
DNDi/MSF Press Release: Millions of Patients Still Waiting for Medical "Breakthroughs" Against Neglected Diseases
December 11, 2012
Grant from UNITAID awarded to bolster development and delivery of child-adapted antiretroviral formulation
December 6, 2012
New Oral Drug Candidate for African Sleeping Sickness
November 13, 2012
DNDi-MMV press release: Open Access Initiative Reveals Drug Hits for Deadly Neglected Tropical Diseases
November 12, 2012
USD 3 Million Awarded to Find Biomarkers for Potential Test of Cure for Chagas Disease
November 8, 2012
International Medical Conference to Assess Progress and Shortcomings of Global Health Revolution for Neglected Patients. Organized by MSF, DNDi and Mount Sinai School of Medicine, Dec 13-14, in New York
October 3, 2012
Cipla-DNDi press release: WHO Prequalifies ASMQ FDC for Malaria. Ready to Be Rolled Out Throughout Asia
September 23, 2012
Brazilian Ministry of Health, Fiocruz and DNDi Latin America to Fight Neglected Diseases through Research and Development Partnership
July 20, 2012
DNDi and Cipla to Develop 4-in-1 Paediatric Antiretroviral Drug Combination to Fill Deadly Gap in Appropriate HIV Medicines
July 2, 2012
DNDi Annual report 2011 is now available!
June 29, 2012
New R&D Director: Dr Graeme Bilbe to Lead DNDi’s R&D Efforts to Address the Treatment Needs of the Most Neglected Patients
June 21, 2012
University of Dundee Awards Honorary Laws Degree to Bernard Pécoul, DNDi Executive Director
June 2012
MSF launches a new NTD report "Fighting the Neglect" - DNDi mentionned as a MSF key partner for R&D
June 12, 2012
Astellas and DNDi to Collaborate on New Drug Discovery Research for the Treatment of Neglected Tropical Diseases

DNDi Scientific publications

Catechol Pyrazolinones as Trypanocidals
Catechol Pyrazolinones as Trypanocidals: Fragment-Based Design, Synthesis, and Pharmacological Evaluation of Nanomolar Inhibitors of Trypanosomal Phosphodiesterase B1 by Orrling KM et al. J. Med. Chem., 2012 September

Anti-Chagas disease compounds "Pharmacological characterization, structural studies, and in vivo activities of anti-Chagas disease lead compounds derived from tipifarnib" by Buckner FS et al. Antimicrob Agents Chemother, 2012 September

Analogues of Fenarimol potent for Chagas Disease "Analogues of Fenarimol Are Potent Inhibitors of Trypanosoma cruzi and Are Efficacious in a Murine Model of Chagas Disease" by Keenan M et al. J. Med. Chem., 2012 December

Treatment for human leishmaniasis "Liposomal amphotericin B as a treatment for human leishmaniasis" by Balasegaram M et al. Expert Opinion on Emerging Drugs, 2012 December

Fexinidazole for Chagas
"Fexinidazole: A Potential New Drug Candidate for Chagas Disease" by Bahia MT et al. PLoS NTDs, 2012 November

Anti-Malarials in Sierra Leone
"Access to Artemisinin-Combination Therapy (ACT) and other Anti-Malarials: National Policy and Markets in Sierra Leone  " by Amuasi JH et al. PLoS One, 2012 October

Effect of AMFm on ACTs
"Effect of the Affordable Medicines Facility—malaria (AMFm) on the availability, price, and market share of quality-assured artemisinin-based combination therapies in seven countries: a before-and-after analysis of outlet survey data" by Tougher S et al. The Lancet, 2012 October

Fexinidazole for HAT
"Genotoxicity profile of fexinidazole - a drug candidate in clinical development for human African trypanomiasis (sleeping sickness)" by Tweats D et al, Mutagenesis, 2012 September

ASMQ in Amazon basin
"Effect of artesunate-mefloquine fixed-dose combination in malaria transmission in amazon basin communities."  by Santelli AC, Ribeiro I et alii. Malaria Journal, 2012 August

Milteflosine for leishmaniasis: a review
"Milteflosine: a review of its pharmacology and therapeutic efficacy in the treatment of leishmaniasis" by Dorlo TPC, Balasegaram M et alii. Journal of Antimicrobial Chemotherapy, 2012 July
DNDi in the media

November 29, 2012
Novethic: "Industrie pharmaceutique: quel accès aux médicaments dans les pays pauvres?"
November 14, 2012
Intellectual Property Watch: "Recent Research Highlights Potential of Open Access in Drug Discovery"
November 3, 2012
ARTE TV "Le Dessous des Cartes" on Neglected Diseases: DNDi model widely showcased, with the example of the sleeping sickness treatment NECT
October 30, 2012
The Lancet "The Affordable Medicines Facility - malaria: killing it slowly"
October 10, 2012
Financial Times Special Report "Combating Neglected Diseases" - DNDi and partners mentioned in 3 articles
October 4, 2012
New Straits Times (Malaysia): "3-day treatment to cure malaria"
October 4, 2012
The Star (Malaysia): "Three-day treatment: latest malaria drug may be available in gvt hospitals in January"
October 3, 2012
The Economic Times (India): "Cipla's anti-malaria drug receives WHO pre-qualification"
October 3, 2012
Correio Braziliense: "Remedio brazileiro vira referência contra a malária" - "Brazilian drug becomes a reference in the fight against malaria"
October 3, 2012
Reuters: "Cipla Malaria drug aimed at Asia gets WHO nod"
July 31, 2012
Financial Times: "Infectious diseases: innovation can still be a matter of life or death"
DNDi Events
Upcoming

April 15-19 2013
Chagas Week
Cochabamba, Bolivia
COHEMI Symposium on NTDs and Migration/International Symposium on Chagas Disease/Chagas Disease Clinical Research Platform Meeting

May 13-17 2013
World Leish 5
Porto de Galinhas, Pernambuco, Brazil
The Fifth World Leishmaniasis Congress is organized by the Oswaldo Cruz Foundation the Brazilian Society of Tropical Medicine, the Brazilian Society of Protozoology, and the Brazilian Society of Parasitology.



Past

December 13-14, 2012
Lives in the Balance: Delivering medical innovations for neglected diseases and populations
New York, USA
This DNDi event was held in the context of the organisation's 10-year anniversary
November 11-15, 2012
ASTMH 2012
Atlanta, USA
DNDi hosted a session on Post-Kala-Azar Dermal Leishmaniasis (PKDL), and was also present with oral presentations and posters.

October 21-24, 2012
World Health Summit
Berlin, Germany
DNDi hosted one session on regulatory issures and giving presentations in others

September 23-27, 2012
ICTMM
Rio de Janeiro, Brazil
DNDi hosts two session of the XVIII International Congress for Tropical Medicine and Malaria

August 17, 2012
Neglected Diseases Forum
Campesinas, Brazil
DNDi co-organizes and participates in a Neglected Diseases Forum hold by Unicamp

July 22-27, 2012
AIDS 2012
Boston, USA
DNDi co-organizes 2 sessions in this premier gathering for those working in the field of HIV.




Except where otherwise noted, content on this site is licensed under a Creative Commons Attribution-Noncommercial-Share Alike 2.5 Switzerland License